| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba4b9d1e01c09bf81dce06ad8e81cd96 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1131
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2bb9a75ab796b42877f764d8040e2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7534be578377bdac6f518ab651c0b372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3284d1f154b3a72bc4a3ab1e4e703a9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead69e60618ef357a8f91884cf60d7a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b75baf0611951f0ef3f6ca23846af7a |
| publicationDate |
2015-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2015211680-A |
| titleOfInvention |
Short hairpin RNA for gene expression inhibition |
| abstract |
Methods and compositions related to shRNAs, fractured shRNAs, and T-shaped RNAs for use in gene silencing. (A) a guide strand consisting of 15 to 19 nucleotides and at least partially complementary to a target nucleotide sequence, wherein the target nucleotide sequence is a viral sequence; and (b) 10 A shRNA molecule comprising a passenger strand consisting of nucleotides to 19 nucleotides and at least partially complementary to at least a portion of the guide strand. [Selection] Figure 1 |
| priorityDate |
2008-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |